0001384101-24-000045.txt : 20240319
0001384101-24-000045.hdr.sgml : 20240319
20240319165002
ACCESSION NUMBER: 0001384101-24-000045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chambers Rebecca
CENTRAL INDEX KEY: 0001823563
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36156
FILM NUMBER: 24764214
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DR.
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERACYTE, INC.
CENTRAL INDEX KEY: 0001384101
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 205455398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 243-6300
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: CALDEROME INC
DATE OF NAME CHANGE: 20061219
4
1
wk-form4_1710881393.xml
FORM 4
X0508
4
2024-03-15
0
0001384101
VERACYTE, INC.
VCYT
0001823563
Chambers Rebecca
6000 SHORELINE COURT
SUITE 300
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-03-15
4
A
0
4318
0
A
148891
D
Common Stock
2024-03-15
4
F
0
2189
21.10
D
146702
D
Represents the acquisition of restricted stock units ("RSUs") earned by the Reporting Person upon the achievement of performance goals for the one-year period ended December 31, 2023, as reflected in the
financial statements and certified by the Compensation Committee of the Board of Directors on March 15, 2024. The RSUs vested March 15, 2024.
The reporting person is reporting the withholding of 2,189 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 4,189 Performance Stock
Units vested on March 15, 2024 and does not represent a sale by the reporting person.
/s/ Jonathan Wygant as attorney-in-fact
2024-03-19